Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets

Transfusion

Volumn 52, Issue 2, 2012, Pages 431-439

  Chudy, Michael ^a,b,c,d   Weber Schehl, Marijke ^a,b,c,d   Pichl, Lutz ^a,b,c,d   Jork, Christine ^a,b,c,d   Kress, Julia ^a,b,c,d   Heiden, Margarethe ^a,b,c,d   Funk, Markus B ^a,b,c,d   Nübling, C Micha ^a,b,c,d  

^a PAUL EHRLICH INSTITUT   (Germany)

^b Blutspendedienst des Bayerischen Roten Kreuzes ^*  (Germany)

^c DRK Blutspendedienst West   (Germany)

^d DRK Blutspendedienst NSTOB   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; EVOLUTION; FALSE NEGATIVE RESULT; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; LONG TERMINAL REPEAT; MALE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; SCREENING TEST; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BLOOD DONORS; DNA PROBES; FALSE NEGATIVE REACTIONS; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, VIRAL; VIRAL LOAD;

EID: 84855821986     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03281.x     Document Type: Article

References (18)

1. Joint United Nations Program on AIDS (UNAIDS). Report on the global AIDS epidemic. Chapter 2: Status of the global HIV epidemic. 2008. [cited 01 Aug 2008]. Available from: URL
2. Offergeld R, Ritter S, Quabeck L, Hamouda O,. Infektionsepidemiologische Daten von Blutspendern in Deutschland 2007. Bundesgesundheitsbl- Gesundheitsforsch-Gesundheitsschutz 2010; 11: 1188-96.
3. Bekanntmachung über die Ergebnisse des Stufenplanverfahrens zur Verminderung des Risikos von Hepatitis B-, Hepatitis C- und HIV-Infektionen bei Empfängern von Erythrozytenkonzentraten (BAnz. Nr. 63 vom 04.04.97, S. 4477) vom 25.Februar 1998. Bundesanzeiger 1998; 53: 12269-70.
4. Verminderung des Risikos von HIV -1-Infektionen durch zelluläre Blutprodukte und gefrorenes Frischplasma Anordnung der Testung auf HIV -1-RNA mit Nukleinsäure-Amplifikationstechniken. Bundesanzeiger 2003; 103: 3835-6.
5. Nubling CM, Chudy M, Lower J,. Validation of HCV-NAT assays and experience with NAT application for blood screening in Germany. Biologicals 1999; 27: 291-4. (Pubitemid 30150759)
6. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal of the European Communities 1998; 7.12.98 L 331/1-37. Available from: URL
7. Holmes H, Davis C, Heath A, Hewlett I, Lelie N,. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001; 92: 141-50. (Pubitemid 32171982)
8. Nubling CM, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk MB,. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2009; 49: 1850-8.
9. Schmidt M, Korn K, Nuebling CM, Chudy M, Kress J, Horst HA, Geusendam G, Hennig H, Sireis W, Rabenau H, Doerr HW, Berger A, Hourfar MK, Gubbe K, Karl A, Fickenscher H, Tischer K, Babiel R, Seifried E, Guertler L,. First transmission of HIV-1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion 2009; 49: 1836-44.
10. Scott L, Carmona S, Stevens W,. Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan Version 2.0 human immunodeficiency virus Type 1 assay. J Clin Microbiol 2009; 47: 3400-02.
11. Pas S, Rossen JW, Schoener D, Thamke D, Pettersson A, Babiel R, Schutten M,. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2010; 48: 1195-200.
12. Drosten C, Panning M, Drexler JF, Hansel F, Pedroso C, Yeats J, Souza Luna LK, Samuel M, Liedigk B, Lippert U, Sturmer M, Doerr HW, Brites C, Preiser W,. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5′ long terminal repeat domain. Clin Chem 2006; 52: 1258-66. (Pubitemid 43956016)
13. Stadhouders R, Pas SD, Anber J, Voermans J, Mes TH, Schutten M,. The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5′ nuclease assay. J Mol Diagn 2010; 12: 109-17.
14. Christopherson C, Sninsky J, Kwok S,. The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies. Nucleic Acids Res 1997; 25: 654-8. (Pubitemid 27298251)
15. Foglieni B, Candotti D, Guarnori I, Raffaele L, Berzuini A, Spreafico M, Orani A, Rossotti R, Rossi D, Allain JP, Prati D,. A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion 2011; 51: 719-30. 2010 Nov 18 (Epub ahead of print; doi: 10.1111/j.1537-2995.2010.02942.x).
16. Edelmann A, Kalus U, Oltmann A, Stein A, Unbehaun A, Drosten C, Kruger DH, Hofmann J,. Improvement of an ultrasensitive human immunodeficiency virus type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region. Transfusion 2010; 50: 685-92.
17. Laffoon B, Levi M, Bower WA, Brooks JT, Selik RM, Switzer WM, Heneine W, Shankar A, Iuliano AD,. HIV transmission through transfusion-Missouri and Colorado, 2008. MMWR 2010; 59: 1335-6.
18. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W,. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 2011; 364: 236-47.